Cortexyme Announces Webcasts of Investor Conference Presentations in August 2020
Presentations to be webcast on Cortexyme’s website
The Canaccord Genuity 40th Annual Growth Conference: Ms. Lynch’s presentation will start at
2:00 p.m. EDT/ 11:00 a.m. PDTon Wednesday, August 12.
The JMP Securities CNS Forum: Ms. Lynchwill participate in a fireside chat at 1:00 p.m. EDT/ 10:00 a.m.on Wednesday, August 19.
Both events will take place virtually, with live webcasts accessible at the Investor Calendar page under the News & Events heading of the
Statements in this press release contain “forward-looking statements” that are subject to substantial risks and uncertainties. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “expect,” “believe,” “will,” “may,” “should,” “estimate,” “project,” “outlook,” “forecast” or other similar words. Examples of forward-looking statements include, among others, statements we make regarding our business plans and prospects, the translation to humans of pre-clinical data; the pre-clinical results for our product candidates, the timing and success of our clinical trials and related data, the potential of atuzaginstat to treat Alzheimer’s disease and cardiovascular disease, our ability to fund planned operating and capital expenditures, the timing of announcements and updates relating to our clinical trials and related data, the timing of and our ability to enroll patients into our clinical trials, and the potential therapeutic benefits, safety and efficacy of our product candidate or library of compounds. Forward-looking statements are based on Cortexyme’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and could cause actual results to differ materially from what we expect. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ include, but are not limited to, the risks and uncertainties described in the section titled “Risk Factors” in our Annual Report on Form 10-K filed with the
Chief Financial Officer